Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05360680
Title A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cue Biopharma
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.